Home
About
Overview
Sharing Data
ORCID
Help
History (1)
CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response.
CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response. Cell Metab. 2018 01 09; 27(1):85-100.e8.
View in:
PubMed
subject areas
ADP-ribosyl Cyclase 1
Animals
Forkhead Box Protein O1
Glutamine
Immunotherapy
Mice, Inbred C57BL
NAD
Neoplasms
Sirtuin 1
Th1 Cells
Th17 Cells
T-Lymphocytes
authors with profiles
Inhong Kang
Craig Cano Beeson
Lauren Elizabeth Ball
Shikhar Mehrotra
Shahid Husain
Chrystal Mary Paulos
Xuezhong Yu
Meenal Mehrotra
Besim Ogretmen
Kristi L. Helke
Paramita Chakraborty